Shares of RHÖN-KLINIKUM Aktiengesellschaft (ETR:RHK - Get Free Report) dropped 8.5% during trading on Thursday . The stock traded as low as €11.20 ($12.87) and last traded at €11.90 ($13.68). Approximately 24,287 shares traded hands during trading, a decline of 44% from the average daily volume of 43,281 shares. The stock had previously closed at €13.00 ($14.94).
RHÖN-KLINIKUM Aktiengesellschaft Price Performance
The company's 50-day simple moving average is €13.75 and its 200 day simple moving average is €13.95. The firm has a market cap of $790.92 million, a P/E ratio of 17.63, a price-to-earnings-growth ratio of 26.77 and a beta of -0.13.
RHÖN-KLINIKUM Aktiengesellschaft Company Profile
(
Get Free Report)
RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. Its hospitals offer treatment services, including rehabilitation, ophthalmology, pregnancies and births, accident surgery, dentistry, tumors, neurological conditions, and treatment of thoracic, lung, vascular, nerves and the skeletal system, and heart diseases.
Featured Articles
Before you consider RHÖN-KLINIKUM Aktiengesellschaft, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and RHÖN-KLINIKUM Aktiengesellschaft wasn't on the list.
While RHÖN-KLINIKUM Aktiengesellschaft currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.